scholarly article | Q13442814 |
P356 | DOI | 10.1136/ARD.2007.071894 |
P8608 | Fatcat ID | release_odshmyuitnanrpunb6aoxjawlq |
P932 | PMC publication ID | 3055597 |
P698 | PubMed publication ID | 17666450 |
P5875 | ResearchGate publication ID | 6173638 |
P50 | author | Wendy Thomson | Q42653464 |
Deborah P.M. Symmons | Q54100237 | ||
Jane Worthington | Q29998784 | ||
Anne Barton | Q30348373 | ||
P2093 | author name string | A Silman | |
H Naseem | |||
P2860 | cites work | Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins | Q44687984 |
Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene | Q46525978 | ||
Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. | Q46689842 | ||
The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis | Q46897903 | ||
Estimating the incidence of rheumatoid arthritis: Trying to hit a moving target? | Q56446828 | ||
Genetic basis of rheumatoid arthritis | Q56901751 | ||
The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population | Q58234945 | ||
The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis | Q58234961 | ||
STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS | Q61912680 | ||
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis | Q28267921 | ||
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant | Q28280659 | ||
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins | Q31460983 | ||
Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study | Q33951520 | ||
PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis | Q34114509 | ||
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset | Q35637041 | ||
The Norfolk Arthritis Register (NOAR). | Q35669619 | ||
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films | Q41513883 | ||
Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study | Q42599672 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 251-255 | |
P577 | publication date | 2007-07-31 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome | |
P478 | volume | 67 |
Q46840442 | Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis. |
Q64916954 | Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review. |
Q35001270 | Current progress in the pharmacological therapy of fibromyalgia |
Q33923376 | Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort |
Q33665938 | Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists [...] |
Q35053747 | The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis |
Q36456814 | The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA. |
Q34395284 | The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register |
Search more.